APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Valsartan

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Valsartan Market Analysis and Forecast 2026-2032

Report ID 174045020230 December 2025207 pages

Choose your research edition.

Industry ResearchValsartan Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Valsartan Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Valsartan Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valsartan Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Valsartan Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Valsartan market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Valsartan is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Valsartan is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Valsartan is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Valsartan is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Valsartan include Alembic Pharmaceuticals, Amneal Pharmaceuticals, Aurobindo Pharma, HETERO, Huaren Pharmaceutical, Jubilant Pharma, LG Life Sciences, Lupin and Macleods Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Valsartan, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Valsartan, also provides the sales of main regions and countries. Of the upcoming market potential for Valsartan, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Valsartan sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Valsartan market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Valsartan sales, projected growth trends, production technology, application and end-user industry.

Valsartan Segment by Company

Alembic Pharmaceuticals

Amneal Pharmaceuticals

Aurobindo Pharma

HETERO

Huaren Pharmaceutical

Jubilant Pharma

LG Life Sciences

Lupin

Macleods Pharmaceuticals

Square Pharmaceuticals

Torrent Pharmaceuticals

Unichem Laboratories

Mylan

Novartis

Sun Pharmaceutical

Teva

Zhejiang Huahai Pharmaceutical

Valsartan Segment by Type

80 mg Tablets

40 mg Tablets

320 mg Tablets

160 mg Tablets

Valsartan Segment by Application

Heart Failure

Heart Attack

Hypertension

Valsartan Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valsartan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valsartan and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valsartan.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Valsartan in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Valsartan manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Valsartan sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Valsartan Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 80 mg Tablets Major Manufacturers Table 3. 40 mg Tablets Major Manufacturers Table 4. 320 mg Tablets Major Manufacturers Table 5. 160 mg Tablets Major Manufacturers Table 6. Global Valsartan Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Heart Failure Major Manufacturers Table 8. Heart Attack Major Manufacturers Table 9. Hypertension Major Manufacturers Table 10. Valsartan Industry Trends Table 11. Valsartan Industry Drivers Table 12. Valsartan Industry Opportunities and Challenges Table 13. Valsartan Industry Restraints Table 14. Global Valsartan Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Valsartan Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Valsartan Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Valsartan Revenue Market Share by Region (2021-2026) Table 18. Global Valsartan Revenue Market Share by Region (2027-2032) Table 19. Global Valsartan Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Pcs) Table 20. Global Valsartan Sales by Region (2021-2026) & (K Pcs) Table 21. Global Valsartan Sales by Region (2027-2032) & (K Pcs) Table 22. Global Valsartan Sales Market Share by Region (2021-2026) Table 23. Global Valsartan Sales Market Share by Region (2027-2032) Table 24. Global Valsartan Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Valsartan Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Valsartan Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Valsartan Sales Market Share by Manufacturers (2021-2026) Table 28. Global Valsartan Sales Price (US$/Pcs) of Manufacturers (2021-2026) Table 29. Global Valsartan Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Valsartan Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Valsartan Manufacturers, Product Type & Application Table 32. Global Valsartan Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Valsartan by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Valsartan Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Valsartan Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Valsartan Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Valsartan Revenue Market Share by Type (2021-2026) Table 39. Global Valsartan Revenue Market Share by Type (2027-2032) Table 40. Global Valsartan Sales by Type 2021 VS 2025 VS 2032 (K Pcs) Table 41. Global Valsartan Sales by Type (2021-2026) & (K Pcs) Table 42. Global Valsartan Sales by Type (2027-2032) & (K Pcs) Table 43. Global Valsartan Sales Market Share by Type (2021-2026) Table 44. Global Valsartan Sales Market Share by Type (2027-2032) Table 45. Global Valsartan Price by Type (2021-2026) & (US$/Pcs) Table 46. Global Valsartan Price by Type (2027-2032) & (US$/Pcs) Table 47. Global Valsartan Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Valsartan Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Valsartan Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Valsartan Revenue Market Share by Application (2021-2026) Table 51. Global Valsartan Revenue Market Share by Application (2027-2032) Table 52. Global Valsartan Sales by Application 2021 VS 2025 VS 2032 (K Pcs) Table 53. Global Valsartan Sales by Application (2021-2026) & (K Pcs) Table 54. Global Valsartan Sales by Application (2027-2032) & (K Pcs) Table 55. Global Valsartan Sales Market Share by Application (2021-2026) Table 56. Global Valsartan Sales Market Share by Application (2027-2032) Table 57. Global Valsartan Price by Application (2021-2026) & (US$/Pcs) Table 58. Global Valsartan Price by Application (2027-2032) & (US$/Pcs) Table 59. Alembic Pharmaceuticals Company Information Table 60. Alembic Pharmaceuticals Business Overview Table 61. Alembic Pharmaceuticals Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 62. Alembic Pharmaceuticals Valsartan Product Portfolio Table 63. Alembic Pharmaceuticals Recent Development Table 64. Amneal Pharmaceuticals Company Information Table 65. Amneal Pharmaceuticals Business Overview Table 66. Amneal Pharmaceuticals Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 67. Amneal Pharmaceuticals Valsartan Product Portfolio Table 68. Amneal Pharmaceuticals Recent Development Table 69. Aurobindo Pharma Company Information Table 70. Aurobindo Pharma Business Overview Table 71. Aurobindo Pharma Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 72. Aurobindo Pharma Valsartan Product Portfolio Table 73. Aurobindo Pharma Recent Development Table 74. HETERO Company Information Table 75. HETERO Business Overview Table 76. HETERO Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 77. HETERO Valsartan Product Portfolio Table 78. HETERO Recent Development Table 79. Huaren Pharmaceutical Company Information Table 80. Huaren Pharmaceutical Business Overview Table 81. Huaren Pharmaceutical Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 82. Huaren Pharmaceutical Valsartan Product Portfolio Table 83. Huaren Pharmaceutical Recent Development Table 84. Jubilant Pharma Company Information Table 85. Jubilant Pharma Business Overview Table 86. Jubilant Pharma Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 87. Jubilant Pharma Valsartan Product Portfolio Table 88. Jubilant Pharma Recent Development Table 89. LG Life Sciences Company Information Table 90. LG Life Sciences Business Overview Table 91. LG Life Sciences Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 92. LG Life Sciences Valsartan Product Portfolio Table 93. LG Life Sciences Recent Development Table 94. Lupin Company Information Table 95. Lupin Business Overview Table 96. Lupin Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 97. Lupin Valsartan Product Portfolio Table 98. Lupin Recent Development Table 99. Macleods Pharmaceuticals Company Information Table 100. Macleods Pharmaceuticals Business Overview Table 101. Macleods Pharmaceuticals Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 102. Macleods Pharmaceuticals Valsartan Product Portfolio Table 103. Macleods Pharmaceuticals Recent Development Table 104. Square Pharmaceuticals Company Information Table 105. Square Pharmaceuticals Business Overview Table 106. Square Pharmaceuticals Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 107. Square Pharmaceuticals Valsartan Product Portfolio Table 108. Square Pharmaceuticals Recent Development Table 109. Torrent Pharmaceuticals Company Information Table 110. Torrent Pharmaceuticals Business Overview Table 111. Torrent Pharmaceuticals Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 112. Torrent Pharmaceuticals Valsartan Product Portfolio Table 113. Torrent Pharmaceuticals Recent Development Table 114. Unichem Laboratories Company Information Table 115. Unichem Laboratories Business Overview Table 116. Unichem Laboratories Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 117. Unichem Laboratories Valsartan Product Portfolio Table 118. Unichem Laboratories Recent Development Table 119. Mylan Company Information Table 120. Mylan Business Overview Table 121. Mylan Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 122. Mylan Valsartan Product Portfolio Table 123. Mylan Recent Development Table 124. Novartis Company Information Table 125. Novartis Business Overview Table 126. Novartis Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 127. Novartis Valsartan Product Portfolio Table 128. Novartis Recent Development Table 129. Sun Pharmaceutical Company Information Table 130. Sun Pharmaceutical Business Overview Table 131. Sun Pharmaceutical Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 132. Sun Pharmaceutical Valsartan Product Portfolio Table 133. Sun Pharmaceutical Recent Development Table 134. Teva Company Information Table 135. Teva Business Overview Table 136. Teva Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 137. Teva Valsartan Product Portfolio Table 138. Teva Recent Development Table 139. Zhejiang Huahai Pharmaceutical Company Information Table 140. Zhejiang Huahai Pharmaceutical Business Overview Table 141. Zhejiang Huahai Pharmaceutical Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 142. Zhejiang Huahai Pharmaceutical Valsartan Product Portfolio Table 143. Zhejiang Huahai Pharmaceutical Recent Development Table 144. North America Valsartan Revenue by Type (2021-2026) & (US$ Million) Table 145. North America Valsartan Revenue by Type (2027-2032) & (US$ Million) Table 146. North America Valsartan Sales by Type (2021-2026) & (K Pcs) Table 147. North America Valsartan Sales by Type (2027-2032) & (K Pcs) Table 148. North America Valsartan Sales Price by Type (2021-2026) & (US$/Pcs) Table 149. North America Valsartan Sales Price by Type (2027-2032) & (US$/Pcs) Table 150. North America Valsartan Revenue by Application (2021-2026) & (US$ Million) Table 151. North America Valsartan Revenue by Application (2027-2032) & (US$ Million) Table 152. North America Valsartan Sales by Application (2021-2026) & (K Pcs) Table 153. North America Valsartan Sales by Application (2027-2032) & (K Pcs) Table 154. North America Valsartan Sales Price by Application (2021-2026) & (US$/Pcs) Table 155. North America Valsartan Sales Price by Application (2027-2032) & (US$/Pcs) Table 156. North America Valsartan Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. North America Valsartan Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 158. North America Valsartan Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 159. North America Valsartan Sales by Country (2021 VS 2025 VS 2032) & (K Pcs) Table 160. North America Valsartan Sales by Country (2021-2026) & (K Pcs) Table 161. North America Valsartan Sales by Country (2027-2032) & (K Pcs) Table 162. North America Valsartan Sales Price by Country (2021-2026) & (US$/Pcs) Table 163. North America Valsartan Sales Price by Country (2027-2032) & (US$/Pcs) Table 164. United States Valsartan Revenue (2021-2032) & (US$ Million) Table 165. Canada Valsartan Revenue (2021-2032) & (US$ Million) Table 166. Europe Valsartan Revenue by Type (2021-2026) & (US$ Million) Table 167. Europe Valsartan Revenue by Type (2027-2032) & (US$ Million) Table 168. Europe Valsartan Sales by Type (2021-2026) & (K Pcs) Table 169. Europe Valsartan Sales by Type (2027-2032) & (K Pcs) Table 170. Europe Valsartan Sales Price by Type (2021-2026) & (US$/Pcs) Table 171. Europe Valsartan Sales Price by Type (2027-2032) & (US$/Pcs) Table 172. Europe Valsartan Revenue by Application (2021-2026) & (US$ Million) Table 173. Europe Valsartan Revenue by Application (2027-2032) & (US$ Million) Table 174. Europe Valsartan Sales by Application (2021-2026) & (K Pcs) Table 175. Europe Valsartan Sales by Application (2027-2032) & (K Pcs) Table 176. Europe Valsartan Sales Price by Application (2021-2026) & (US$/Pcs) Table 177. Europe Valsartan Sales Price by Application (2027-2032) & (US$/Pcs) Table 178. Europe Valsartan Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Europe Valsartan Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. Europe Valsartan Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. Europe Valsartan Sales by Country (2021 VS 2025 VS 2032) & (K Pcs) Table 182. Europe Valsartan Sales by Country (2021-2026) & (K Pcs) Table 183. Europe Valsartan Sales by Country (2027-2032) & (K Pcs) Table 184. Europe Valsartan Sales Price by Country (2021-2026) & (US$/Pcs) Table 185. Europe Valsartan Sales Price by Country (2027-2032) & (US$/Pcs) Table 186. Germany Valsartan Revenue (2021-2032) & (US$ Million) Table 187. France Valsartan Revenue (2021-2032) & (US$ Million) Table 188. U.K. Valsartan Revenue (2021-2032) & (US$ Million) Table 189. Italy Valsartan Revenue (2021-2032) & (US$ Million) Table 190. Netherlands Valsartan Revenue (2021-2032) & (US$ Million) Table 191. China Valsartan Revenue by Type (2021-2026) & (US$ Million) Table 192. China Valsartan Revenue by Type (2027-2032) & (US$ Million) Table 193. China Valsartan Sales by Type (2021-2026) & (K Pcs) Table 194. China Valsartan Sales by Type (2027-2032) & (K Pcs) Table 195. China Valsartan Sales Price by Type (2021-2026) & (US$/Pcs) Table 196. China Valsartan Sales Price by Type (2027-2032) & (US$/Pcs) Table 197. China Valsartan Revenue by Application (2021-2026) & (US$ Million) Table 198. China Valsartan Revenue by Application (2027-2032) & (US$ Million) Table 199. China Valsartan Sales by Application (2021-2026) & (K Pcs) Table 200. China Valsartan Sales by Application (2027-2032) & (K Pcs) Table 201. China Valsartan Sales Price by Application (2021-2026) & (US$/Pcs) Table 202. China Valsartan Sales Price by Application (2027-2032) & (US$/Pcs) Table 203. Asia Valsartan Revenue by Type (2021-2026) & (US$ Million) Table 204. Asia Valsartan Revenue by Type (2027-2032) & (US$ Million) Table 205. Asia Valsartan Sales by Type (2021-2026) & (K Pcs) Table 206. Asia Valsartan Sales by Type (2027-2032) & (K Pcs) Table 207. Asia Valsartan Sales Price by Type (2021-2026) & (US$/Pcs) Table 208. Asia Valsartan Sales Price by Type (2027-2032) & (US$/Pcs) Table 209. Asia Valsartan Revenue by Application (2021-2026) & (US$ Million) Table 210. Asia Valsartan Revenue by Application (2027-2032) & (US$ Million) Table 211. Asia Valsartan Sales by Application (2021-2026) & (K Pcs) Table 212. Asia Valsartan Sales by Application (2027-2032) & (K Pcs) Table 213. Asia Valsartan Sales Price by Application (2021-2026) & (US$/Pcs) Table 214. Asia Valsartan Sales Price by Application (2027-2032) & (US$/Pcs) Table 215. Asia Valsartan Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 216. Asia Valsartan Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 217. Asia Valsartan Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 218. Asia Valsartan Sales by Country (2021 VS 2025 VS 2032) & (K Pcs) Table 219. Asia Valsartan Sales by Country (2021-2026) & (K Pcs) Table 220. Asia Valsartan Sales by Country (2027-2032) & (K Pcs) Table 221. Asia Valsartan Sales Price by Country (2021-2026) & (US$/Pcs) Table 222. Asia Valsartan Sales Price by Country (2027-2032) & (US$/Pcs) Table 223. Japan Valsartan Revenue (2021-2032) & (US$ Million) Table 224. South Korea Valsartan Revenue (2021-2032) & (US$ Million) Table 225. India Valsartan Revenue (2021-2032) & (US$ Million) Table 226. Australia Valsartan Revenue (2021-2032) & (US$ Million) Table 227. China Taiwan Valsartan Revenue (2021-2032) & (US$ Million) Table 228. Southeast Asia Valsartan Revenue (2021-2032) & (US$ Million) Table 229. SAMEA Valsartan Revenue by Type (2021-2026) & (US$ Million) Table 230. SAMEA Valsartan Revenue by Type (2027-2032) & (US$ Million) Table 231. SAMEA Valsartan Sales by Type (2021-2026) & (K Pcs) Table 232. SAMEA Valsartan Sales by Type (2027-2032) & (K Pcs) Table 233. SAMEA Valsartan Sales Price by Type (2021-2026) & (US$/Pcs) Table 234. SAMEA Valsartan Sales Price by Type (2027-2032) & (US$/Pcs) Table 235. SAMEA Valsartan Revenue by Application (2021-2026) & (US$ Million) Table 236. SAMEA Valsartan Revenue by Application (2027-2032) & (US$ Million) Table 237. SAMEA Valsartan Sales by Application (2021-2026) & (K Pcs) Table 238. SAMEA Valsartan Sales by Application (2027-2032) & (K Pcs) Table 239. SAMEA Valsartan Sales Price by Application (2021-2026) & (US$/Pcs) Table 240. SAMEA Valsartan Sales Price by Application (2027-2032) & (US$/Pcs) Table 241. SAMEA Valsartan Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 242. SAMEA Valsartan Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 243. SAMEA Valsartan Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 244. SAMEA Valsartan Sales by Country (2021 VS 2025 VS 2032) & (K Pcs) Table 245. SAMEA Valsartan Sales by Country (2021-2026) & (K Pcs) Table 246. SAMEA Valsartan Sales by Country (2027-2032) & (K Pcs) Table 247. SAMEA Valsartan Sales Price by Country (2021-2026) & (US$/Pcs) Table 248. SAMEA Valsartan Sales Price by Country (2027-2032) & (US$/Pcs) Table 249. Brazil Valsartan Revenue (2021-2032) & (US$ Million) Table 250. Argentina Valsartan Revenue (2021-2032) & (US$ Million) Table 251. Chile Valsartan Revenue (2021-2032) & (US$ Million) Table 252. Colombia Valsartan Revenue (2021-2032) & (US$ Million) Table 253. Peru Valsartan Revenue (2021-2032) & (US$ Million) Table 254. Saudi Arabia Valsartan Revenue (2021-2032) & (US$ Million) Table 255. Israel Valsartan Revenue (2021-2032) & (US$ Million) Table 256. UAE Valsartan Revenue (2021-2032) & (US$ Million) Table 257. Turkey Valsartan Revenue (2021-2032) & (US$ Million) Table 258. Iran Valsartan Revenue (2021-2032) & (US$ Million) Table 259. Egypt Valsartan Revenue (2021-2032) & (US$ Million) Table 260. Key Raw Materials Table 261. Raw Materials Key Suppliers Table 262. Valsartan Distributors List Table 263. Valsartan Customers List Table 264. Research Programs/Design for This Report Table 265. Authors List of This Report Table 266. Secondary Sources Table 267. Primary Sources List of Figures Figure 1. Valsartan Image Figure 2. Global Valsartan Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valsartan Market Size Share 2021 VS 2025 VS 2032 Figure 4. 80 mg Tablets Image Figure 5. 40 mg Tablets Image Figure 6. 320 mg Tablets Image Figure 7. 160 mg Tablets Image Figure 8. Global Valsartan Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Valsartan Market Size Share 2021 VS 2025 VS 2032 Figure 10. Heart Failure Image Figure 11. Heart Attack Image Figure 12. Hypertension Image Figure 13. Global Valsartan Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Valsartan Revenue (2021-2032) & (US$ Million) Figure 15. Global Valsartan Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Valsartan Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Valsartan Revenue Market Share by Region (2021-2032) Figure 18. Global Valsartan Sales (2021-2032) & (K Pcs) Figure 19. Global Valsartan Sales by Region: 2021 VS 2025 VS 2032 (K Pcs) Figure 20. Global Valsartan Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Valsartan Sales YoY (2021-2032) & (K Pcs) Figure 22. Europe Valsartan Sales YoY (2021-2032) & (K Pcs) Figure 23. China Valsartan Sales YoY (2021-2032) & (K Pcs) Figure 24. Asia (Excluding China) Valsartan Sales YoY (2021-2032) & (K Pcs) Figure 25. South America, Middle East and Africa Valsartan Sales YoY (2021-2032) & (K Pcs) Figure 26. Global Valsartan Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Valsartan Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Valsartan Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Valsartan Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Valsartan Revenue Market Share by Type (2021-2032) Figure 32. Global Valsartan Sales by Type (2021 VS 2025 VS 2032) & (K Pcs) Figure 33. Global Valsartan Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Valsartan Sales Market Share by Type (2021-2032) Figure 35. Global Valsartan Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Valsartan Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Valsartan Revenue Market Share by Application (2021-2032) Figure 38. Global Valsartan Sales by Application (2021 VS 2025 VS 2032) & (K Pcs) Figure 39. Global Valsartan Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Valsartan Sales Market Share by Application (2021-2032) Figure 41. North America Valsartan Revenue Share by Type (2021-2032) Figure 42. North America Valsartan Sales Share by Type (2021-2032) Figure 43. North America Valsartan Revenue Share by Application (2021-2032) Figure 44. North America Valsartan Sales Share by Application (2021-2032) Figure 45. North America Valsartan Revenue Share by Country (2021-2032) Figure 46. North America Valsartan Sales Share by Country (2021-2032) Figure 47. Europe Valsartan Revenue Share by Type (2021-2032) Figure 48. Europe Valsartan Sales Share by Type (2021-2032) Figure 49. Europe Valsartan Revenue Share by Application (2021-2032) Figure 50. Europe Valsartan Sales Share by Application (2021-2032) Figure 51. Europe Valsartan Revenue Share by Country (2021-2032) Figure 52. Europe Valsartan Sales Share by Country (2021-2032) Figure 53. China Valsartan Revenue Share by Type (2021-2032) Figure 54. China Valsartan Sales Share by Type (2021-2032) Figure 55. China Valsartan Revenue Share by Application (2021-2032) Figure 56. China Valsartan Sales Share by Application (2021-2032) Figure 57. Asia Valsartan Revenue Share by Type (2021-2032) Figure 58. Asia Valsartan Sales Share by Type (2021-2032) Figure 59. Asia Valsartan Revenue Share by Application (2021-2032) Figure 60. Asia Valsartan Sales Share by Application (2021-2032) Figure 61. Asia Valsartan Revenue Share by Country (2021-2032) Figure 62. Asia Valsartan Sales Share by Country (2021-2032) Figure 63. SAMEA Valsartan Revenue Share by Type (2021-2032) Figure 64. SAMEA Valsartan Sales Share by Type (2021-2032) Figure 65. SAMEA Valsartan Revenue Share by Application (2021-2032) Figure 66. SAMEA Valsartan Sales Share by Application (2021-2032) Figure 67. SAMEA Valsartan Revenue Share by Country (2021-2032) Figure 68. SAMEA Valsartan Sales Share by Country (2021-2032) Figure 69. Valsartan Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Valsartan Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 80 mg Tablets
  • 40 mg Tablets
  • 320 mg Tablets
  • 160 mg Tablets
Applications
  • Heart Failure
  • Heart Attack
  • Hypertension
Companies covered
  • Alembic Pharmaceuticals
  • Amneal Pharmaceuticals
  • Aurobindo Pharma
  • HETERO
  • Huaren Pharmaceutical
  • Jubilant Pharma
  • LG Life Sciences
  • Lupin
  • Macleods Pharmaceuticals
  • Square Pharmaceuticals
  • Torrent Pharmaceuticals
  • Unichem Laboratories
  • Mylan
  • Novartis
  • Sun Pharmaceutical
  • Teva
  • Zhejiang Huahai Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Valsartan Market by Type
  3. 1.2.1 Global Valsartan Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 80 mg Tablets
  5. 1.2.3 40 mg Tablets
  6. 1.2.4 320 mg Tablets
  7. 1.2.5 160 mg Tablets
  8. 1.3 Valsartan Market by Application
  9. 1.3.1 Global Valsartan Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Heart Failure
  11. 1.3.3 Heart Attack
  12. 1.3.4 Hypertension
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Valsartan Market Dynamics
  1. 2.1 Valsartan Industry Trends
  2. 2.2 Valsartan Industry Drivers
  3. 2.3 Valsartan Industry Opportunities and Challenges
  4. 2.4 Valsartan Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Valsartan Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Valsartan Revenue by Region
  3. 3.2.1 Global Valsartan Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Valsartan Revenue by Region (2021-2026)
  5. 3.2.3 Global Valsartan Revenue by Region (2027-2032)
  6. 3.2.4 Global Valsartan Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Valsartan Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Valsartan Sales by Region
  9. 3.4.1 Global Valsartan Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Valsartan Sales by Region (2021-2026)
  11. 3.4.3 Global Valsartan Sales by Region (2027-2032)
  12. 3.4.4 Global Valsartan Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Valsartan Revenue by Manufacturers
  2. 4.1.1 Global Valsartan Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Valsartan Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Valsartan Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Valsartan Sales by Manufacturers
  6. 4.2.1 Global Valsartan Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Valsartan Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Valsartan Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Valsartan Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Valsartan Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Valsartan Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Valsartan Manufacturers, Product Type & Application
  13. 4.7 Global Valsartan Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Valsartan Market CR5 and HHI
  16. 4.8.2 2025 Valsartan Tier 1, Tier 2, and Tier 3
5 Valsartan Market by Type
  1. 5.1 Global Valsartan Revenue by Type
  2. 5.1.1 Global Valsartan Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Valsartan Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Valsartan Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Valsartan Sales by Type
  6. 5.2.1 Global Valsartan Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Valsartan Sales by Type (2021-2032) & (K Pcs)
  8. 5.2.3 Global Valsartan Sales Market Share by Type (2021-2032)
  9. 5.3 Global Valsartan Price by Type
6 Valsartan Market by Application
  1. 6.1 Global Valsartan Revenue by Application
  2. 6.1.1 Global Valsartan Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Valsartan Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Valsartan Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Valsartan Sales by Application
  6. 6.2.1 Global Valsartan Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Valsartan Sales by Application (2021-2032) & (K Pcs)
  8. 6.2.3 Global Valsartan Sales Market Share by Application (2021-2032)
  9. 6.3 Global Valsartan Price by Application
7 Company Profiles
  1. 7.1 Alembic Pharmaceuticals
  2. 7.1.1 Alembic Pharmaceuticals Company Information
  3. 7.1.2 Alembic Pharmaceuticals Business Overview
  4. 7.1.3 Alembic Pharmaceuticals Valsartan Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Alembic Pharmaceuticals Valsartan Product Portfolio
  6. 7.1.5 Alembic Pharmaceuticals Recent Developments
  7. 7.2 Amneal Pharmaceuticals
  8. 7.2.1 Amneal Pharmaceuticals Company Information
  9. 7.2.2 Amneal Pharmaceuticals Business Overview
  10. 7.2.3 Amneal Pharmaceuticals Valsartan Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Amneal Pharmaceuticals Valsartan Product Portfolio
  12. 7.2.5 Amneal Pharmaceuticals Recent Developments
  13. 7.3 Aurobindo Pharma
  14. 7.3.1 Aurobindo Pharma Company Information
  15. 7.3.2 Aurobindo Pharma Business Overview
  16. 7.3.3 Aurobindo Pharma Valsartan Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Aurobindo Pharma Valsartan Product Portfolio
  18. 7.3.5 Aurobindo Pharma Recent Developments
  19. 7.4 HETERO
  20. 7.4.1 HETERO Company Information
  21. 7.4.2 HETERO Business Overview
  22. 7.4.3 HETERO Valsartan Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 HETERO Valsartan Product Portfolio
  24. 7.4.5 HETERO Recent Developments
  25. 7.5 Huaren Pharmaceutical
  26. 7.5.1 Huaren Pharmaceutical Company Information
  27. 7.5.2 Huaren Pharmaceutical Business Overview
  28. 7.5.3 Huaren Pharmaceutical Valsartan Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Huaren Pharmaceutical Valsartan Product Portfolio
  30. 7.5.5 Huaren Pharmaceutical Recent Developments
  31. 7.6 Jubilant Pharma
  32. 7.6.1 Jubilant Pharma Company Information
  33. 7.6.2 Jubilant Pharma Business Overview
  34. 7.6.3 Jubilant Pharma Valsartan Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Jubilant Pharma Valsartan Product Portfolio
  36. 7.6.5 Jubilant Pharma Recent Developments
  37. 7.7 LG Life Sciences
  38. 7.7.1 LG Life Sciences Company Information
  39. 7.7.2 LG Life Sciences Business Overview
  40. 7.7.3 LG Life Sciences Valsartan Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 LG Life Sciences Valsartan Product Portfolio
  42. 7.7.5 LG Life Sciences Recent Developments
  43. 7.8 Lupin
  44. 7.8.1 Lupin Company Information
  45. 7.8.2 Lupin Business Overview
  46. 7.8.3 Lupin Valsartan Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Lupin Valsartan Product Portfolio
  48. 7.8.5 Lupin Recent Developments
  49. 7.9 Macleods Pharmaceuticals
  50. 7.9.1 Macleods Pharmaceuticals Company Information
  51. 7.9.2 Macleods Pharmaceuticals Business Overview
  52. 7.9.3 Macleods Pharmaceuticals Valsartan Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Macleods Pharmaceuticals Valsartan Product Portfolio
  54. 7.9.5 Macleods Pharmaceuticals Recent Developments
  55. 7.10 Square Pharmaceuticals
  56. 7.10.1 Square Pharmaceuticals Company Information
  57. 7.10.2 Square Pharmaceuticals Business Overview
  58. 7.10.3 Square Pharmaceuticals Valsartan Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Square Pharmaceuticals Valsartan Product Portfolio
  60. 7.10.5 Square Pharmaceuticals Recent Developments
  61. 7.11 Torrent Pharmaceuticals
  62. 7.11.1 Torrent Pharmaceuticals Company Information
  63. 7.11.2 Torrent Pharmaceuticals Business Overview
  64. 7.11.3 Torrent Pharmaceuticals Valsartan Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Torrent Pharmaceuticals Valsartan Product Portfolio
  66. 7.11.5 Torrent Pharmaceuticals Recent Developments
  67. 7.12 Unichem Laboratories
  68. 7.12.1 Unichem Laboratories Company Information
  69. 7.12.2 Unichem Laboratories Business Overview
  70. 7.12.3 Unichem Laboratories Valsartan Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Unichem Laboratories Valsartan Product Portfolio
  72. 7.12.5 Unichem Laboratories Recent Developments
  73. 7.13 Mylan
  74. 7.13.1 Mylan Company Information
  75. 7.13.2 Mylan Business Overview
  76. 7.13.3 Mylan Valsartan Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Mylan Valsartan Product Portfolio
  78. 7.13.5 Mylan Recent Developments
  79. 7.14 Novartis
  80. 7.14.1 Novartis Company Information
  81. 7.14.2 Novartis Business Overview
  82. 7.14.3 Novartis Valsartan Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Novartis Valsartan Product Portfolio
  84. 7.14.5 Novartis Recent Developments
  85. 7.15 Sun Pharmaceutical
  86. 7.15.1 Sun Pharmaceutical Company Information
  87. 7.15.2 Sun Pharmaceutical Business Overview
  88. 7.15.3 Sun Pharmaceutical Valsartan Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Sun Pharmaceutical Valsartan Product Portfolio
  90. 7.15.5 Sun Pharmaceutical Recent Developments
  91. 7.16 Teva
  92. 7.16.1 Teva Company Information
  93. 7.16.2 Teva Business Overview
  94. 7.16.3 Teva Valsartan Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Teva Valsartan Product Portfolio
  96. 7.16.5 Teva Recent Developments
  97. 7.17 Zhejiang Huahai Pharmaceutical
  98. 7.17.1 Zhejiang Huahai Pharmaceutical Company Information
  99. 7.17.2 Zhejiang Huahai Pharmaceutical Business Overview
  100. 7.17.3 Zhejiang Huahai Pharmaceutical Valsartan Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Zhejiang Huahai Pharmaceutical Valsartan Product Portfolio
  102. 7.17.5 Zhejiang Huahai Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Valsartan Market Size by Type
  2. 8.1.1 North America Valsartan Revenue by Type (2021-2032)
  3. 8.1.2 North America Valsartan Sales by Type (2021-2032)
  4. 8.1.3 North America Valsartan Price by Type (2021-2032)
  5. 8.2 North America Valsartan Market Size by Application
  6. 8.2.1 North America Valsartan Revenue by Application (2021-2032)
  7. 8.2.2 North America Valsartan Sales by Application (2021-2032)
  8. 8.2.3 North America Valsartan Price by Application (2021-2032)
  9. 8.3 North America Valsartan Market Size by Country
  10. 8.3.1 North America Valsartan Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Valsartan Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Valsartan Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Valsartan Market Size by Type
  2. 9.1.1 Europe Valsartan Revenue by Type (2021-2032)
  3. 9.1.2 Europe Valsartan Sales by Type (2021-2032)
  4. 9.1.3 Europe Valsartan Price by Type (2021-2032)
  5. 9.2 Europe Valsartan Market Size by Application
  6. 9.2.1 Europe Valsartan Revenue by Application (2021-2032)
  7. 9.2.2 Europe Valsartan Sales by Application (2021-2032)
  8. 9.2.3 Europe Valsartan Price by Application (2021-2032)
  9. 9.3 Europe Valsartan Market Size by Country
  10. 9.3.1 Europe Valsartan Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Valsartan Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Valsartan Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Valsartan Market Size by Type
  2. 10.1.1 China Valsartan Revenue by Type (2021-2032)
  3. 10.1.2 China Valsartan Sales by Type (2021-2032)
  4. 10.1.3 China Valsartan Price by Type (2021-2032)
  5. 10.2 China Valsartan Market Size by Application
  6. 10.2.1 China Valsartan Revenue by Application (2021-2032)
  7. 10.2.2 China Valsartan Sales by Application (2021-2032)
  8. 10.2.3 China Valsartan Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Valsartan Market Size by Type
  2. 11.1.1 Asia Valsartan Revenue by Type (2021-2032)
  3. 11.1.2 Asia Valsartan Sales by Type (2021-2032)
  4. 11.1.3 Asia Valsartan Price by Type (2021-2032)
  5. 11.2 Asia Valsartan Market Size by Application
  6. 11.2.1 Asia Valsartan Revenue by Application (2021-2032)
  7. 11.2.2 Asia Valsartan Sales by Application (2021-2032)
  8. 11.2.3 Asia Valsartan Price by Application (2021-2032)
  9. 11.3 Asia Valsartan Market Size by Country
  10. 11.3.1 Asia Valsartan Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Valsartan Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Valsartan Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Valsartan Market Size by Type
  2. 12.1.1 SAMEA Valsartan Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Valsartan Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Valsartan Price by Type (2021-2032)
  5. 12.2 SAMEA Valsartan Market Size by Application
  6. 12.2.1 SAMEA Valsartan Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Valsartan Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Valsartan Price by Application (2021-2032)
  9. 12.3 SAMEA Valsartan Market Size by Country
  10. 12.3.1 SAMEA Valsartan Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Valsartan Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Valsartan Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Valsartan Value Chain Analysis
  2. 13.1.1 Valsartan Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Valsartan Production Mode & Process
  6. 13.2 Valsartan Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Valsartan Distributors
  9. 13.2.3 Valsartan Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst